Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Read more

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Read more

Complete Spinal Cord Injury

We are developing an innovative treatment that aims to improve the patients’ quality of life.

Read more

Press releases

• October 21, 2018 - Regulatory press releaseBioArctic is granted a concept patent in Europe for the company’s strategy for disease-modifying treatment of Parkinson’s disease
• October 18, 2018 - Other press releaseBioArctic: Eisai to present additional data from BAN2401 Phase 2b study in early Alzheimer’s disease and the presentation will be webcast live from CTAD
• October 3, 2018 - Regulatory press releaseBioArctic receives European patent protection for a medical device for treatment of patients with Complete Spinal Cord Injury

Archive

Interim Report January – June 2018

BioArctic AB published the company’s Interim Report January – June 2018 on Thursday, August 23.

• Report
• Presentation
• Webcast

Read the report

Calendar

• October 25, 2018BioArctic’s partner Eisai to present additional data from BAN2401 Phase 2b study in early Alzheimer’s disease
• November 8, 2018Interim Report January – September 2018
• November 14, 2018 - November 15, 2018Jefferies 2018 London Healthcare Conference

All events